Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization

The epidermal growth factor receptor (EGFR) is known to play a critical role in non-small cell lung cancer (NSCLC). Constitutively active EGFR mutations, including in-frame deletion in exon 19 and L858R point mutation in exon 21, contribute about 90% of all EGFR-activating mutations in NSCLC. Althou...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yiu To Yeung, Shuying Yin, Bingbing Lu, Suyu Fan, Ran Yang, Ruihua Bai, Chengjuan Zhang, Ann M. Bode, Kangdong Liu, Zigang Dong
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2018-02-01
Col·lecció:	EBioMedicine
Matèries:	Non-small cell lung cancer (NSCLC) Gefitinib resistance Tetraploidization p38 mitogen activating protein kinase (MAPK) Losmapimod
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2352396418300215
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!